[go: up one dir, main page]

ZA908778B - Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products - Google Patents

Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products

Info

Publication number
ZA908778B
ZA908778B ZA908778A ZA908778A ZA908778B ZA 908778 B ZA908778 B ZA 908778B ZA 908778 A ZA908778 A ZA 908778A ZA 908778 A ZA908778 A ZA 908778A ZA 908778 B ZA908778 B ZA 908778B
Authority
ZA
South Africa
Prior art keywords
immunoassays
monoclonal antibodies
degradation products
prothrombin activation
activation peptides
Prior art date
Application number
ZA908778A
Other languages
English (en)
Inventor
Marcie Jones Hursting
Jones Hursting Marcie
Bryan Timothy Butman
Timothy Butman Bryan
Jerald Paul Steiner
Paul Steiner Jerald
Bryant Mckoy Moore
Mckoy Moore Bryant
Frederick Anthony Dombrose
Anthony Dombrose Frederick
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23714193&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA908778(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA908778B publication Critical patent/ZA908778B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
ZA908778A 1989-11-06 1990-11-01 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products ZA908778B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43196489A 1989-11-06 1989-11-06

Publications (1)

Publication Number Publication Date
ZA908778B true ZA908778B (en) 1991-10-30

Family

ID=23714193

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA908778A ZA908778B (en) 1989-11-06 1990-11-01 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products

Country Status (15)

Country Link
US (1) US5830681A (xx)
EP (1) EP0594576B1 (xx)
JP (1) JP2918688B2 (xx)
KR (1) KR100202773B1 (xx)
AT (1) ATE182366T1 (xx)
AU (1) AU655918B2 (xx)
CA (1) CA2071211C (xx)
DE (1) DE69033220T2 (xx)
DK (1) DK0594576T3 (xx)
ES (1) ES2136598T3 (xx)
FI (1) FI109204B (xx)
GR (1) GR3031607T3 (xx)
IE (1) IE903930A1 (xx)
WO (1) WO1991006861A1 (xx)
ZA (1) ZA908778B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727610A1 (de) 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US5942443A (en) 1996-06-28 1999-08-24 Caliper Technologies Corporation High throughput screening assay systems in microscale fluidic devices
NZ333346A (en) * 1996-06-28 2000-03-27 Caliper Techn Corp High-throughput screening assay systems in microscale fluidic devices
AUPP460398A0 (en) * 1998-07-10 1998-08-06 Life Therapeutics Limited Lupus anticoagulant
JP2003524187A (ja) * 2000-02-23 2003-08-12 ベッスト−テスト アンパーツゼルスカブ 体液、例えば尿におけるマーカーと血液凝固活性とを相互関連づけるための方法
US20020098516A1 (en) * 2000-10-03 2002-07-25 Boystown National Research Hospital Immunodiagnostic determination of usher syndrome type IIA
DE10354403A1 (de) 2003-11-20 2005-06-23 Dade Behring Marburg Gmbh Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
DE102004042124B4 (de) * 2004-08-30 2006-07-06 Dade Behring Marburg Gmbh Homogenes Verfahren zur Bestimmung eines Analyten in Gegenwart eines Überschusses von kreuzreagierenden Substanzen
KR100967614B1 (ko) * 2008-03-14 2010-07-05 주식회사 바이오인프라 Ｄｅｓ－Ｒ 프로트롬빈 활성 펩티드 단편 Ｆ２의 혈청 내농도 측정을 통한 암의 진단 및 스크리닝 방법
DE102008049601A1 (de) 2008-09-30 2010-04-01 Siemens Healthcare Diagnostics Products Gmbh Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
WO2010141131A1 (en) 2009-06-04 2010-12-09 Lockheed Martin Corporation Multiple-sample microfluidic chip for dna analysis
WO2012051529A1 (en) 2010-10-15 2012-04-19 Lockheed Martin Corporation Micro fluidic optic design
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
EP4239338A1 (de) 2022-03-03 2023-09-06 Siemens Healthcare Diagnostics Products GmbH Globaltest zur feststellung des status des blutgerinnungssystems
CN118829936A (zh) 2022-04-26 2024-10-22 依视路国际公司 具有镜面涂层的光致变色光学制品
EP4325224A1 (de) 2022-08-18 2024-02-21 Siemens Healthcare Diagnostics Products GmbH Thrombozytenaktivierungstest zur diagnose einer heparin-induzierten thrombozytopenie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727610A1 (de) * 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung

Also Published As

Publication number Publication date
CA2071211A1 (en) 1991-05-07
DE69033220D1 (de) 1999-08-26
FI109204B (fi) 2002-06-14
AU6956391A (en) 1991-05-31
FI922017L (fi) 1992-05-05
AU655918B2 (en) 1995-01-19
US5830681A (en) 1998-11-03
KR100202773B1 (ko) 1999-06-15
WO1991006861A1 (en) 1991-05-16
JPH05504473A (ja) 1993-07-15
DE69033220T2 (de) 2000-01-20
CA2071211C (en) 2003-02-18
GR3031607T3 (en) 2000-01-31
JP2918688B2 (ja) 1999-07-12
ES2136598T3 (es) 1999-12-01
ATE182366T1 (de) 1999-08-15
IE903930A1 (en) 1991-05-08
EP0594576A4 (en) 1993-03-15
DK0594576T3 (da) 2000-02-07
EP0594576B1 (en) 1999-07-21
FI922017A0 (fi) 1992-05-05
EP0594576A1 (en) 1994-05-04

Similar Documents

Publication Publication Date Title
ZA908778B (en) Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products
SG44845A1 (en) Recombitant anti-vla4 antibody molecules
GR3029740T3 (en) Fragments of prion proteins.
MY109957A (en) Improved antibodies to plasmodium falciparum
IL126314A (en) Monoclonal antibodies having an antigen binding region specific for the extracellular domain of prostate specific membrane antigen (psma)
NO913186L (no) Fremgangsmaate for anvendelse og syntese av peptider.
DE69619493D1 (de) Polypeptid-dendrimer komplexe
AU676859B2 (en) Synthetic peptides, antibodies against them and their use
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
BR9809778A (pt) Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.
ATE296312T1 (de) Metalkomplexbildner
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
DE69132122D1 (de) Reinigung von cytokeratinfragmenten
JPS5516290A (en) Purified antigen for testing against neisseria gonorrhoeae antibody
IL93207A0 (en) A monoclonal antibody which binds to factor betaxiia and shows no substantial binding to factor xii
ES8504257A1 (es) Un metodo para determinar antigenos estreptococales en una muestra clinica
CA2054689A1 (en) An immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen
ATE280229T1 (de) Enterotoxine von shigella flexneri 2a
DK329789D0 (da) Monoklonalt antistof
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
EP0343946A3 (en) Cea fragments
PT81050A (en) Anti-urokinase monoclonal antibody and process for preparing biochemical test kits which use it
ATE130200T1 (de) Neue verwendung für einen monoklonalen antikörper.
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens
GB2333295A (en) Modified protein G and fragments thereof